CRUS CRUS
Company Profile ↓Company Overview
CRUS (CRUS) is a publicly traded company listed on . The valuation, growth and price-trend signals below summarize what matters most to investors and traders evaluating the stock.
Why Investors Should Care
Generates a return on equity of 19.5%, reflecting efficient use of shareholder capital.
Return on capital employed stands at 20.1%.
Net profit has compounded at 16.0% per year over the last five years.
Revenue has grown at a 14.8% CAGR over the past five years.
Trades at an undemanding P/E of 16.5.
Maintains a net profit margin of 20.8%.
Recent Developments
- Mar 2026 Revenue of $2.00B (+5.3% YoY); net profit $414.41M.
- Trailing 12 Months Year-on-year growth — revenue +5.3%, earnings +25.0%.
- 5-Year Trend Long-term compounding — revenue CAGR 14.8%, profit CAGR 16.0%.
Growth & Price Performance
Compounded Sales Growth
| 5 Years: | 14.75% |
| 1 Year: | 5.34% |
Compounded Profit Growth
| 5 Years: | 16.03% |
| 1 Year: | 25.01% |
Stock Price Performance
| 1 Year: | +22.58% |
| 6 Months: | +3.89% |
| 3 Months: | -24.41% |
| 1 Month: | -11.70% |
Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.
- Price vs 50-DMABelow
- Price vs 200-DMABelow
- RSI (14)35.55 · Neutral
Auto-generated from price history and fundamentals; not investment advice.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth Charts
No fundamental data available for this stock.
Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.
PROS
- Healthy ROCE of 20.1%.
- Excellent profit margin of 20.8%.
- Compounding revenue at 14.8% over 5 years.
- Profit CAGR of 16.0% over 5 years.
- Generates positive free cash flow.
- In a confirmed uptrend (50-DMA above 200-DMA).
CONS
- Trading 27.7% below its 52-week high.
* The pros and cons are auto-generated from financial metrics.
Valuation
Growth (CAGR)
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios
Quarterly Results
Figures in USD.
| Metric | Mar 2015 | Jun 2015 | Sep 2015 | Dec 2015 | Mar 2016 | Jun 2016 | Sep 2016 | Dec 2016 | Mar 2017 | Jun 2017 | Sep 2017 | Dec 2017 | Mar 2018 | Jun 2018 | Sep 2018 | Dec 2018 | Mar 2019 | Jun 2019 | Sep 2019 | Dec 2019 | Mar 2020 | Jun 2020 | Sep 2020 | Dec 2020 | Mar 2021 | Jun 2021 | Sep 2021 | Dec 2021 | Jun 2022 | Sep 2022 | Dec 2022 | Jun 2023 | Sep 2023 | Dec 2023 | Jun 2024 | Sep 2024 | Dec 2024 | Jun 2025 | Sep 2025 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - | - | - | - | 320.74M | 425.54M | 482.74M | 303.17M | 254.48M | 366.31M | 324.30M | 240.44M | 238.25M | 388.91M | 374.67M | 279.29M | 242.57M | 347.32M | 485.80M | 293.54M | 277.25M | 465.89M | 548.35M | 393.64M | 540.57M | 590.58M | 317.02M | 481.06M | 618.98M | 374.03M | 541.86M | 555.74M | 407.27M | 560.96M | 580.62M |
| Gross Profit | 118.97M | 132.45M | 142.22M | 164.91M | 115.25M | 126.69M | 211.70M | 255.15M | 164.28M | 161.72M | 211.28M | 235.09M | 152.63M | 124.56M | 185.12M | 163.18M | 124.64M | 122.49M | 207.93M | 197.50M | 146.24M | 127.47M | 180.21M | 251.50M | 148.12M | 139.95M | 235.44M | 289.52M | 202.63M | 271.29M | 296.70M | 159.39M | 246.60M | 317.46M | 188.93M | 282.59M | 297.79M | 214.03M | 294.37M | 308.13M |
| Operating Income | - | 50.00M | 44.11M | 63.91M | - | 22.21M | 103.94M | 146.19M | - | 47.30M | 90.89M | 103.51M | - | -6.16M | 55.58M | 44.24M | - | 4.14M | 86.68M | 72.68M | - | 18.68M | 64.15M | 129.65M | - | 19.10M | 95.20M | 144.17M | 54.28M | 116.22M | 141.38M | 17.79M | 105.75M | 167.55M | 46.79M | 131.85M | 145.77M | 72.39M | 144.76M | 152.93M |
| Net Income | 21.35M | 33.35M | 34.88M | 41.38M | 14.01M | 18.07M | 86.04M | 122.04M | 35.06M | 42.91M | 73.30M | 33.78M | 12.00M | -4.27M | 58.17M | 29.93M | 6.16M | 4.62M | 76.21M | 68.51M | 10.16M | 18.21M | 59.49M | 114.37M | 25.28M | 17.21M | 85.10M | 127.64M | 39.71M | 87.19M | 103.48M | 15.60M | 75.41M | 138.72M | 42.09M | 102.14M | 116.00M | 60.70M | 131.60M | 140.31M |
| Diluted EPS | 0.32 | 0.50 | 0.53 | 0.63 | 0.21 | 0.27 | 1.30 | 1.83 | 0.52 | 0.64 | 1.10 | 0.52 | 0.19 | -0.07 | 0.93 | 0.49 | 0.10 | 0.08 | 1.27 | 1.13 | 0.17 | 0.30 | 0.99 | 1.91 | 0.42 | 0.29 | 1.43 | 2.16 | 0.69 | 1.52 | 1.83 | 0.28 | 1.34 | 2.50 | 0.76 | 1.83 | 2.11 | 1.14 | 2.48 | 2.66 |
| R&D Expense | - | 65.83M | 67.26M | 70.29M | - | 73.93M | 75.67M | 76.08M | - | 83.56M | 90.35M | 96.98M | - | 97.93M | 96.38M | 88.58M | - | 88.83M | 88.24M | 88.71M | - | 78.74M | 84.81M | 89.44M | - | 85.70M | 102.12M | 107.10M | 109.72M | 115.47M | 118.06M | 106.22M | 104.20M | 112.67M | 105.36M | 112.92M | 112.98M | 102.89M | 110.02M | 113.55M |
Profit & Loss (Annual)
Figures in USD.
| Metric | Mar 2010 | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 220.99M | 369.57M | 426.84M | 809.79M | 714.34M | 916.57M | 1.17B | 1.54B | 1.53B | 1.19B | 1.28B | 1.37B | 1.78B | 1.90B | 1.79B | 1.90B | 2.00B |
| Gross Profit | 118.73M | 202.00M | 230.44M | 395.19M | 356.16M | 425.75M | 554.84M | 757.82M | 760.72M | 597.50M | 674.17M | 707.30M | 923.64M | 956.98M | 916.07M | 996.04M | 1.05B |
| Operating Income | 25.40M | 83.33M | 79.54M | 200.83M | 155.02M | 108.77M | 180.21M | 317.05M | 262.46M | 100.77M | 173.48M | 237.18M | 366.34M | 249.03M | 343.47M | 410.36M | 460.38M |
| Net Income | 38.40M | 203.50M | 87.98M | 136.60M | 108.11M | 55.18M | 123.63M | 261.21M | 162.00M | 89.99M | 159.50M | 217.34M | 326.36M | 176.70M | 274.57M | 331.51M | 414.41M |
| Diluted EPS | 0.59 | 2.82 | 1.29 | 2.00 | 1.65 | 0.85 | 1.87 | 3.92 | 2.46 | 1.46 | 2.64 | 3.62 | 5.52 | 3.09 | 4.90 | 6.00 | 7.85 |
| R&D Expense | 51.42M | 63.93M | 85.70M | 114.07M | 126.19M | 197.88M | 269.22M | 303.66M | 366.44M | 375.14M | 347.65M | 342.76M | 406.31M | 458.41M | 426.48M | 434.68M | 433.95M |
Balance Sheet (Annual)
Figures in USD.
| Metric | Mar 2009 | Mar 2010 | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | - | - | 496.62M | 544.46M | 651.35M | 724.74M | 1.15B | 1.18B | 1.41B | 1.43B | 1.35B | 1.59B | 1.83B | 2.12B | 2.06B | 2.23B | 2.33B | 2.49B |
| Total Equity | 172.93M | 218.60M | 438.38M | 465.86M | 548.17M | 637.36M | 756.77M | 859.48M | 1.15B | 1.16B | 1.14B | 1.23B | 1.39B | 1.60B | 1.66B | 1.82B | 1.95B | 2.13B |
| Cash & Equivalents | 31.50M | 16.11M | 37.04M | 66.00M | 66.40M | 31.85M | 76.40M | 168.79M | 351.17M | 235.60M | 216.17M | 292.12M | 442.16M | 369.81M | 445.78M | 502.76M | 539.62M | 800.93M |
| Current Liabilities | - | - | 52.05M | 72.98M | 93.08M | 82.52M | 176.58M | 128.12M | 144.07M | 140.21M | 115.54M | 158.64M | 213.61M | 264.78M | 216.34M | 186.39M | 195.19M | 194.66M |
Cash Flows (Annual)
Figures in USD.
| Metric | Mar 2010 | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | 25.14M | 86.94M | 83.19M | 160.82M | - | - | 149.05M | 369.75M | 318.71M | 206.69M | 295.81M | 348.94M | 124.75M | 339.57M | 421.67M | 444.37M | 650.60M |
| Investing Cash Flow | -42.56M | -74.25M | 18.44M | -84.80M | -220.35M | -324.40M | 20.24M | -69.86M | -184.72M | -54.66M | -100.22M | -77.67M | -18.37M | -33.33M | -163.01M | -124.28M | -75.12M |
| Financing Cash Flow | 2.03M | 8.24M | -72.67M | -75.62M | - | - | -76.90M | -117.51M | -249.56M | -171.46M | -119.65M | -121.22M | -178.73M | -230.27M | -201.68M | -283.23M | -314.17M |
| Capital Expenditure | -3.65M | -20.06M | -35.95M | -52.90M | -15.06M | -32.31M | -41.57M | -41.85M | -55.18M | -31.61M | -15.66M | -18.25M | -26.14M | -35.09M | -37.65M | -22.78M | -13.99M |
| Free Cash Flow | 21.48M | 66.88M | 47.25M | 107.92M | - | - | 107.48M | 327.90M | 263.53M | 175.08M | 280.16M | 330.69M | 98.61M | 304.48M | 384.02M | 421.59M | 636.61M |
| Share Buybacks | - | 22.77M | 76.78M | 86.06M | 52.14M | 10.53M | 60.50M | 15.44M | 175.78M | 160.00M | 120.00M | 109.99M | 167.50M | 191.38M | 186.00M | 261.02M | 279.96M |
Ratios (Annual)
Figures in %.
| Metric | Mar 2010 | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin % | 53.7% | 54.7% | 54.0% | 48.8% | 49.9% | 46.5% | 47.5% | 49.2% | 49.6% | 50.4% | 52.6% | 51.7% | 51.8% | 50.4% | 51.2% | 52.5% | 52.8% |
| Operating Margin % | 11.5% | 22.5% | 18.6% | 24.8% | 21.7% | 11.9% | 15.4% | 20.6% | 17.1% | 8.5% | 13.5% | 17.3% | 20.6% | 13.1% | 19.2% | 21.6% | 23.0% |
| Net Margin % | 17.4% | 55.1% | 20.6% | 16.9% | 15.1% | 6.0% | 10.6% | 17.0% | 10.6% | 7.6% | 12.4% | 15.9% | 18.3% | 9.3% | 15.3% | 17.5% | 20.7% |
| ROE % | 17.6% | 46.4% | 18.9% | 24.9% | 17.0% | 7.3% | 14.4% | 22.7% | 13.9% | 7.9% | 13.0% | 15.6% | 20.4% | 10.7% | 15.1% | 17.0% | 19.5% |
| ROCE % | - | 18.7% | 16.9% | 36.0% | 24.1% | 11.2% | 17.1% | 25.0% | 20.3% | 8.1% | 12.1% | 14.7% | 19.7% | 13.5% | 16.8% | 19.2% | 20.1% |
Shareholding Pattern
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for CRUS
Cirrus Logic (CRUS) Stock Still Looks Below Fair Value After A 63% Gain - Yahoo Finance
<a href="https://news.google.com/rss/articles/CBMimgFBVV95cUxONnFyWENrTWNhRkhaSFM3SnVLcFBnY1RkR1ZreW00el9pb1c1SHp3R3BFSk4tMDNuTkd5LXVtM01XV0YyNTJlU3JfeExHNm5UbHZHN1B6QV91WWQ4cFBlTFZDZ2l6Wk16ODcxUVFBZmFpWmxvR21fZDlEZXJfQ1ZmUE1BRTZEMDJZZ2tQT0…
Cirrus Logic Inc (CRUS) Stock Down 3.1% but Still Overvalued -- GF Score: 80/100 - GuruFocus
<a href="https://news.google.com/rss/articles/CBMirwFBVV95cUxOQU43OHJYZTI4LUVRU2h0ZXl1cGhFSWgxZmc2OGdvYmg3aGNrZDUwNXhHaWJMYmZWbXBFX2FuVGh6S0MyLWpKQTBaWm81aTByREd0ZkNRX3JIc09FRjNrNVMyVXZ3NDhKelBOSG5RQTBOZ0tSUllrMlhJRDUtTGludDYyOU8wcE5OMXlIU1…
Cirrus Logic (CRUS) Stock Still Looks Discounted As Cash Flow Holds Up - simplywall.st
<a href="https://news.google.com/rss/articles/CBMi0gFBVV95cUxNV0NDdWVOMjJtZ05GSEJFWUtabkVKcmNLUEZPVWxaU19JeHNDdVVxSHNBbGNZcGoxOTZuYk9aQ3RHTVNNYWczX2gwZmxRZEFLTzVIbEg0Sk5BekVMWTBodEZqTDZXb1BVNThocjhJVWFmanF0NHE4Yzk5SU1LektBUVhwOE5qaWk2OHZhYl…
Cirrus Logic plunges as Q1 results show weaker-than-expected audio sales - Seeking Alpha
<a href="https://news.google.com/rss/articles/CBMirwFBVV95cUxOZG9UOXVZOEppc0V4XzFwNEpKNGNtU3JNbG9tZXVOTnVudTByOUdGMDRPSjlUTVRoSERCTER1OXh3OTAwTENsanNXR2ItdE55enVTTXMydVBBVG5zWXd0LTFqQ2NSSUtlRGZNal96T3lBbVAwWG9IQjNSb1lOUnJ4MUo0eFdfSEdjb1h0aD…
Amundi Has $17.46 Million Stock Holdings in Cirrus Logic, Inc. $CRUS - MarketBeat
<a href="https://news.google.com/rss/articles/CBMiwgFBVV95cUxOQ2NieVE0cGs4SXc3eko4RkZGRzBLTjk1ZmJQMGZQVUNNX1R5UUVsWlp5NEtxR19KY0EyVklWUDlRYjk3eHlZT2poRkZHaHlQWkRiSDZyU0dta3VORnVDSld1ZEhXYTMtWXdfeC1NaGJTaTRJSkJIZVl3emNZaTRpLS1mSVJvLWh5Z0NuZX…
Cirrus Logic (NASDAQ: CRUS) details 2026 director and pay votes - Stock Titan
<a href="https://news.google.com/rss/articles/CBMiqAFBVV95cUxPVUN0Z3VuZHpnN21QZDVnUWxsQ0gtWGd4MGYtOXBzenNncWNSNWh6VTlhbm9uZnN2a1dUeVhlalR4c1lMVzk3TzVPUzRZQmdYbDVydlVEd2JJTzhWOGo2d3RHOEFhOENnZWpGTndsUFhRTWgzaVh0dWlFZlozSkQ5NWFzN1NfSVBXTkVMNk…
CRUS — Frequently Asked Questions
What is the current share price of CRUS?
As of 2026-08-05 17:25 PDT, CRUS trades at $129.42 on NASDAQ/NYSE. Its 52-week range is $97.25 to $178.90.
What is the P/E ratio of CRUS?
CRUS trades at a trailing price-to-earnings (P/E) ratio of 16.49.
What is the return on equity (ROE) of CRUS?
CRUS has a return on equity (ROE) of 19.47%. Its return on capital employed (ROCE) is 20.06%.
Is CRUS a good stock to buy?
This page provides a data-driven analysis of CRUS, including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.